Tania Mead

Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease

Roland W. Bürli, Christopher A. Luckhurst, Omar Aziz et al. · Journal of Medicinal Chemistry · 2013 · 149 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Nanofiber-Based Delivery of Therapeutic Peptides to the Brain

Mariarosa Mazza, Rebecca Notman, Jamshed Anwar et al. · ACS Nano · 2013 · 84 citations

Pharmacy, Neuroscience, Pharmaceutics +17

Assessment of Chloroquine Treatment for Modulating Autophagy Flux in Brain of WT and HD Mice

Petr Vodička, Junghyun Lim, Dana T. Williams et al. · Journal of Huntington s Disease · 2014 · 41 citations

Life Sciences, Neuroscience, Pharmacology +17

Lead Optimization toward Proof-of-Concept Tools for Huntington’s Disease within a 4-(1<i>H</i>-Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors

John Wityak, Kevin F. McGee, Michael P. Conlon et al. · Journal of Medicinal Chemistry · 2015 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Dynamics of Aβ42 Reduction in Plasma, CSF and Brain of Rats Treated with the γ-Secretase Modulator, GSM-10h

Julie A. Hawkins, David C. Harrison, Sharlin Ahmed et al. · Neurodegenerative Diseases · 2011 · 33 citations

Life Sciences, Neuroscience, Pharmacology +17